- Ultra-pure and endotoxin-free synthetic oligodeoxynucleotides
- Potent and specific immune cell stimulation in human and mouse
- Optimized protocols with buffers included
Our TLR 7/8/9 antagonists consist of short single-stranded oligodeoxynucleotides (ODNs) with different sequences that can neutralize the stimulatory effect of TLR agonists. TLR antagonists can inhibit CpG ODN-mediated activation of TLR9 and/or activation of TLR7/8. We offer four TLR antagonists and controls with distinct inhibitory capacities.